INE Wins Four Cybersecurity Awards in 12th Annual Global InfoSec Awards at #RSAC 2024
May 07, 2024 07:02 ET
|
INE
San Francisco, CA, May 07, 2024 (GLOBE NEWSWIRE) -- INE, a leading provider of cybersecurity certifications and training, is proud to announce it has won four Global InfoSec Awards during RSAC...
Bioinformatic Collaboration and Licensing Deals Analysis Report and Directory 2024
May 07, 2024 07:01 ET
|
Research and Markets
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Bioinformatic Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Bioinformatic Collaboration and...
Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 07, 2024 07:01 ET
|
Prelude Therapeutics, Inc.
First-in-class IV SMARCA2 degrader, PRT3789 and potentially best-in-class CDK9 inhibitor, PRT2527 remain on track to generate initial proof-of-concept data in 2024 New preclinical data presented at...
First Watch Restaurant Group, Inc. Reports Strong Q1 2024 Financial Results
May 07, 2024 07:00 ET
|
First Watch Restaurant Group, Inc.
Total revenues increased 14.7%; same-restaurant sales growth of 0.5%*Income from operations margin of 5.1% and restaurant level operating profit margin of 20.8%Net income of $7.2 million and Adjusted...
Molecular Diagnostics Collaboration and Licensing Deals Analysis Report 2024 with Directory of 740 Agreements Signed Since 2019
May 07, 2024 07:00 ET
|
Research and Markets
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Molecular Diagnostics Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Molecular Diagnostics...
Ascot Announces C$5.0 Million Non-Brokered Flow Through Private Placement
May 07, 2024 07:00 ET
|
Ascot Resources Ltd.
VANCOUVER, British Columbia, May 07, 2024 (GLOBE NEWSWIRE) -- Ascot Resources Ltd. (TSX: AOT; OTCQX: AOTVF) (“Ascot” or the “Company”) is pleased to announce a C$5.0 million non-brokered flow...
BioCryst to Present at Upcoming Investor Conferences
May 07, 2024 07:00 ET
|
BioCryst Pharmaceuticals, Inc.
RESEARCH TRIANGLE PARK, N.C., May 07, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the following conferences: Citizens JMP...
Meritage Homes Announces Pricing of Convertible Senior Notes
May 07, 2024 07:00 ET
|
Meritage Homes Corporation
SCOTTSDALE, Ariz., May 07, 2024 (GLOBE NEWSWIRE) -- Meritage Homes Corporation (NYSE: MTH, “Meritage” or the “Company”), the fifth-largest homebuilder in the U.S., today announced the pricing of...
Orchard Therapeutics Announces Multiple Presentations at ASGCT 2024
May 07, 2024 07:00 ET
|
Orchard Therapeutics (Europe) Limited
TOKYO, LONDON and BOSTON, May 07, 2024 (GLOBE NEWSWIRE) -- Orchard Therapeutics, recently acquired by Kyowa Kirin with the goal of accelerating the delivery of new gene therapies to patients around...
Arvinas Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 07, 2024 07:00 ET
|
Arvinas Inc.
– Continued enrollment globally in multiple clinical studies of vepdegestrant in ER+/HER2- metastatic breast cancer, including the VERITAC-2 Phase 3 trial in the second-line setting and the study...